Breast cancer
427 results
1 - 100
Overdiagnosis of breast cancer is common- Pedigree identifies hereditary breast cancer syndromes
- Breast cancer screening benefits overrated
- European guidelines on breast cancer screening 2020
- Preventing breast cancer effective in postmenopausal women
- Pooled analysis: SERMs prevent breast cancer
- Unequal breast cancer risk with HRT progestagens
- Paroxetine blocks effect of tamoxifen on breast cancer
- Screening mammography overdiagnoses women with breast cancer
- Oophorectomy associated with decreased breast cancer, ovarian cancer in BRCA mutations
- Breast cancer prevented in some women with drug treatment
- Small benefit to breast cancer screening for most women
- IVF treatment not associated with increased risk of breast cancer
- Exemestane superior to tamoxifen in premenopausal women with breast cancer
- The risk of breast cancer overdiagnosis is high for older women
- Soy associated with less risk of breast cancer recurrence and death
- Atypia on mammogram does not portend breast cancer in the short term
- Modern hormonal contraception associated with increased risk of breast cancer
- Calcium + Vitamin D = placebo in preventing breast cancer (WHI)
- USPSTF: Offer medication to prevent breast cancer to women at risk
- Topical vaginal estrogen is not associated with increased risk in breast cancer survivors
- Exemestane reduces breast cancer risk in high-risk postmenopausal women
- Breast cancer screening with MRI: more false-positives, more biopsies
- Two thirds of reduction in breast cancer mortality due to therapy advances
- Extended duration of letrozole for ER+ breast cancer reduces recurrence but not mortality
- Small increase in risk for breast cancer associated with levonorgestrel-releasing intrauterine device
- Yoga + meditation decreases short-term menopausal suffering in breast cancer survivors
- Acupuncture may reduce aromatase inhibitor–related arthralgia in women with breast cancer
- Aspirin does not reduce the risk of recurrence or improve survival in adults with breast cancer
- Having a primary care doc is assoc with better outcomes in women with breast cancer
- Anastrozole decreases rate of breast cancer in high-risk postmenopausal women (IBIS-II)
- Screening for breast cancer: False-positive rates 60% over 10 years
- 10 years of tamoxifen better than 5 in women with ER+ breast cancer (ATLAS)
- Upper-body weight lifting does not increase women's risk of breast cancer-related lymphedema
- Tibetan yoga modestly improves fatigue and sleep quality in women with breast cancer undergoing chemotherapy
- Even before the new guidelines, a majority of women stated a preference for breast cancer screening in their 40s
- Women with ER+/HER-/node- breast cancer and intermediate Oncotype score do not benefit from chemo (TAILORx)
- USPSTF 2019 recommends offering risk-reducing medication to women at increased risk of breast cancer (B recommendation)
- Extended follow-up: anastrozole better than placebo to prevent breast cancer in high-risk women (IBIS-II)
- Supplemental MRI screening in women with very dense breasts reduces interval cancer rate but may cause overdiagnosis (DENSE)
- 20-year follow-up of WHI trials: lower breast cancer mortality with CEE alone, no difference with CEE plus progesterone